Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Targets Antimicrobials For 'Human Use Only' In Bid To Tackle Resistance

Executive Summary

In the latest effort to address the growing problem of antimicrobial resistance, the EU authorities are consulting on a list of products that must not be used in animals, in order to help preserve their efficacy in humans.

You may also be interested in...



New EU Body To Take The Strain As Talks On Pharma Overhaul Near

A new EU subcommittee is to be set up to advise on matters relating to pharmaceuticals, the European Medicines Agency and public health.

EMA Aligns Antibiotics Guideline To Help Facilitate Global Trials

The EU regulator says it supports a globally aligned approach to the development of new antimicrobial medicines.

Partnerships Are Key To Sustainable mRNA Vaccine Production In LMICs

Low- and middle-income countries need to have the know-how, capability and capacity to produce mRNA vaccines, from concept, design and testing through to manufacturing and registration, a conference heard this week.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS146153

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel